chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administration of first dose to patient younger than 18 years old; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jul-2021 and was forwarded to Moderna on 27-Jul-2021.    This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration of first dose to patient younger than 18 years old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration of first dose to patient younger than 18 years old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration of first dose to patient younger than 18 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided by the reporter.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Nausea
Clinical narrative: vaccine felt really warm going into arm; a little dizzy; Slightly nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (vaccine felt really warm going into arm), DIZZINESS (a little dizzy) and NAUSEA (Slightly nauseous) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FEELING HOT (vaccine felt really warm going into arm), DIZZINESS (a little dizzy) and NAUSEA (Slightly nauseous). At the time of the report, FEELING HOT (vaccine felt really warm going into arm), DIZZINESS (a little dizzy) and NAUSEA (Slightly nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment information was mentioned.   This case was linked to MOD-2021-270022 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: COVID-arm; Itchy/ itchy, red area at injection site; Red spot where the vaccine site was/red area at injection site; red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID-arm), VACCINATION SITE PRURITUS (Itchy/ itchy, red area at injection site), VACCINATION SITE ERYTHEMA (Red spot where the vaccine site was/red area at injection site) and VACCINATION SITE RASH (red rash at injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer and Osteoporosis. Concomitant products included LETROZOLE from 30-Mar-2020 to an unknown date for Breast cancer, DIAPLEX for Digestion impaired, TURMERIC [CURCUMA LONGA RHIZOME] for Disorder joint, ALENDRONATE SODIUM (FOSAMAX) for Osteoporosis, COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 20-Jul-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced VACCINATION COMPLICATION (COVID-arm), VACCINATION SITE PRURITUS (Itchy/ itchy, red area at injection site), VACCINATION SITE ERYTHEMA (Red spot where the vaccine site was/red area at injection site) and VACCINATION SITE RASH (red rash at injection site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D) (oral) for Adverse event, at an unspecified dose and frequency and HYDROCORTISONE from 29-Jul-2021 to 31-Jul-2021 for Adverse event, at an unspecified dose and frequency. On 03-Aug-2021, VACCINATION COMPLICATION (COVID-arm), VACCINATION SITE PRURITUS (Itchy/ itchy, red area at injection site), VACCINATION SITE ERYTHEMA (Red spot where the vaccine site was/red area at injection site) and VACCINATION SITE RASH (red rash at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included unspecified supplements, Aromatase inhibitor and Catalyn.  The patient reported the red rash and itchiness appeared on 29-Jul-2021 and grew in size to about 3 by 3 inches over the next two days.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow-up received provided no new information. On 04-Aug-2021: ADR form received provided patient details, concomitant ad treatment medications, additional event and updated outcome.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided. The reporter states that the  patient received a dose of the Moderna COVID-19 Vaccine that expired on 25 July 2021.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a dose from a vial 24 hs after it was punctured; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a dose from a vial 24 hs after it was punctured) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     Not applicable.     On 27-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a dose from a vial 24 hs after it was punctured). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received a dose from a vial 24 hs after it was punctured) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Non significant follow up
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Product administered to patient of inappropriate age
Clinical narrative: has been sick; is under 18 years old and received a shot of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (is under 18 years old and received a shot of the Moderna vaccine) and ILLNESS (has been sick) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (is under 18 years old and received a shot of the Moderna vaccine). On an unknown date, the patient experienced ILLNESS (has been sick). On 26-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (is under 18 years old and received a shot of the Moderna vaccine) had resolved. At the time of the report, ILLNESS (has been sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug details were reported. No treatment details were reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Caller received the 1st dose of the Moderna vaccine on 04May2021, but hasn't been able to; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Caller received the 1st dose of the Moderna vaccine on 04May2021, but hasn't been able to) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Caller received the 1st dose of the Moderna vaccine on 04May2021, but hasn't been able to). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Caller received the 1st dose of the Moderna vaccine on 04May2021, but hasn't been able to) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in the injected arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in the injected arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness in the injected arm). At the time of the report, VACCINATION SITE PAIN (Soreness in the injected arm) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.   Reporter did not allow further contact
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.     On 26-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). On 26-Jul-2021, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant history was not reported. The treatment history was not provided. The reporter said the patient received a dose of the Moderna COVID-19 Vaccine that expired on July 25th.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Gave 1 shot 1 day past BuD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave 1 shot 1 day past BuD) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave 1 shot 1 day past BuD). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave 1 shot 1 day past BuD) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.   No treatment medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Product dose omission issue
Clinical narrative: Got the first dose of the Moderna vaccine on 02Mar2021 and has not got the second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got the first dose of the Moderna vaccine on 02Mar2021 and has not got the second dose yet) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got the first dose of the Moderna vaccine on 02Mar2021 and has not got the second dose yet). The patient was treated with PARACETAMOL (TYLENOL) in 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got the first dose of the Moderna vaccine on 02Mar2021 and has not got the second dose yet) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Heart rate: rapid (High) Rapid heart beat recovered after an hour and a half.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Waited 5 months to get the second dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jul-2021 and was forwarded to Moderna on 28-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Waited 5 months to get the second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Waited 5 months to get the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Waited 5 months to get the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Family Members suffer adverse events to the Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Family Members suffer adverse events to the Moderna Covid-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Family Members suffer adverse events to the Moderna Covid-19 vaccine). At the time of the report, VACCINATION COMPLICATION (Family Members suffer adverse events to the Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: nausea after second shot; This spontaneous case was reported by a patient and describes the occurrence of NAUSEA (nausea after second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea after second shot). At the time of the report, NAUSEA (nausea after second shot) outcome was unknown.            No concomitants and treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm hurts after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurts after receiving the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurts after receiving the vaccine). At the time of the report, VACCINATION SITE PAIN (Arm hurts after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: gave two Moderna vaccines that were expired by 14 hours/ the vaccine was in a punctured vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave two Moderna vaccines that were expired by 14 hours/ the vaccine was in a punctured vial) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave two Moderna vaccines that were expired by 14 hours/ the vaccine was in a punctured vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave two Moderna vaccines that were expired by 14 hours/ the vaccine was in a punctured vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  Treatment information was not provided.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by reporter. No Treatment medications were provided by reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Therapeutic response unexpected
Clinical narrative: did not have hot flashes for 3-4 days after getting the first dose; arm soreness; felling "drug out tired"; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (did not have hot flashes for 3-4 days after getting the first dose), PAIN IN EXTREMITY (arm soreness) and FATIGUE (felling "drug out tired") in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Hormone replacement therapy (four (4) years ago her doctor took her off hormone replacement therapy). Concurrent medical conditions included Hot flashes. Concomitant products included AMLODIPINE, SERTRALINE, LISINOPRIL, CARVEDILOL and ATORVASTATIN for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (did not have hot flashes for 3-4 days after getting the first dose), PAIN IN EXTREMITY (arm soreness) and FATIGUE (felling "drug out tired"). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (did not have hot flashes for 3-4 days after getting the first dose), PAIN IN EXTREMITY (arm soreness) and FATIGUE (felling "drug out tired") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment information was unknown.   This case was linked to MOD-2021-270015 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Neurological symptom
Clinical narrative: severe and possibly life changing neurological or other side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NEUROLOGICAL SYMPTOM (severe and possibly life changing neurological or other side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEUROLOGICAL SYMPTOM (severe and possibly life changing neurological or other side effects). At the time of the report, NEUROLOGICAL SYMPTOM (severe and possibly life changing neurological or other side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. List of concomitant medication were not given.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Pyrexia
Clinical narrative: muscle aches; Fever of 99.6 degrees Farenheight; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle aches) and PYREXIA (Fever of 99.6 degrees Farenheight) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026LZ0A) for COVID-19 vaccination.     No medical history was reported by the reporter.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced MYALGIA (muscle aches) and PYREXIA (Fever of 99.6 degrees Farenheight). At the time of the report, MYALGIA (muscle aches) and PYREXIA (Fever of 99.6 degrees Farenheight) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 99.6 (High) Fever of 99.6 degrees Fahrenheit..         Concomitant medication included steroids. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-269887 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Parent missed their 2nd dose, past 36 days.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Parent missed their 2nd dose, past 36 days.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical information was provided by reporter.     On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Parent missed their 2nd dose, past 36 days.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Parent missed their 2nd dose, past 36 days.) had resolved.            Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 6 months past due for my second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (6 months past due for my second dose) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (6 months past due for my second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (6 months past due for my second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Therapeutic response unexpected
Clinical narrative: did not have hot flashes for 6-7 days after getting the second dose; arm soreness (2nd Dose); felling "drug out tired" ( 2nd Dose); This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (did not have hot flashes for 6-7 days after getting the second dose), MYALGIA (arm soreness (2nd Dose)) and FATIGUE (felling "drug out tired" ( 2nd Dose)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21-2A and 018B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, SERTRALINE, LISINOPRIL, CARVEDILOL and ATORVASTATIN for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (did not have hot flashes for 6-7 days after getting the second dose), MYALGIA (arm soreness (2nd Dose)) and FATIGUE (felling "drug out tired" ( 2nd Dose)). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (did not have hot flashes for 6-7 days after getting the second dose), MYALGIA (arm soreness (2nd Dose)) and FATIGUE (felling "drug out tired" ( 2nd Dose)) outcome was unknown.            Treatment received was not provided by the reporter.   This case was linked to MOD-2021-269984 (Patient Link).
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Nausea, Pain
Clinical narrative: Nauseous; Fever; Chills; Headache; Sick; Arm hurt; Arm became tender; Arm became swollen; Arm became achy; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), PAIN IN EXTREMITY (Arm hurt), TENDERNESS (Arm became tender), SWELLING (Arm became swollen) and PAIN (Arm became achy) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 11-Jan-2021, Gout attack (Gout attack in his ankle 2 Months ago.) and Sinus infection (sinus infection 2 months ago.).    On 26-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced ILLNESS (Sick), PAIN IN EXTREMITY (Arm hurt), TENDERNESS (Arm became tender), SWELLING (Arm became swollen) and PAIN (Arm became achy). On 27-Jul-2021, the patient experienced NAUSEA (Nauseous), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of 1 dosage form. On 28-Jul-2021, NAUSEA (Nauseous), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, ILLNESS (Sick), TENDERNESS (Arm became tender), SWELLING (Arm became swollen) and PAIN (Arm became achy) outcome was unknown and PAIN IN EXTREMITY (Arm hurt) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  On 28-Jul-2021 the patient's arm still continues to hurt. He was still alternating medications. He already feels better.   Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: Non-significant information regarding contact and communication.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Swelling, Tenderness
Clinical narrative: Nauseous; Fever; Chills; Headache; Sick; Arm hurt; Arm became tender; Arm became swollen; Arm became achy; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), PAIN IN EXTREMITY (Arm hurt), TENDERNESS (Arm became tender), SWELLING (Arm became swollen) and PAIN (Arm became achy) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 11-Jan-2021, Gout attack (Gout attack in his ankle 2 Months ago.) and Sinus infection (sinus infection 2 months ago.).    On 26-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced ILLNESS (Sick), PAIN IN EXTREMITY (Arm hurt), TENDERNESS (Arm became tender), SWELLING (Arm became swollen) and PAIN (Arm became achy). On 27-Jul-2021, the patient experienced NAUSEA (Nauseous), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of 1 dosage form. On 28-Jul-2021, NAUSEA (Nauseous), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, ILLNESS (Sick), TENDERNESS (Arm became tender), SWELLING (Arm became swollen) and PAIN (Arm became achy) outcome was unknown and PAIN IN EXTREMITY (Arm hurt) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  On 28-Jul-2021 the patient's arm still continues to hurt. He was still alternating medications. He already feels better.   Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: Non-significant information regarding contact and communication.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported. Treatment medications were not reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose administered past 36 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered past 36 days) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered past 36 days). On 20-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered past 36 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs, Lab data, Treatment information, if any, not provided.   This case was linked to MOD-2021-269938 (Patient Link).
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Didn't receive second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Didn't receive second dose) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Didn't receive second dose). On 16-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Didn't receive second dose) had resolved.            No concomitant medications were reported.  No treatment medications were reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Limb discomfort, Muscle spasms, Muscular weakness, Pain in extremity
Clinical narrative: Did not receive the 2nd dose because of fear; Weakness and aching on her leg; Aching on her leg; Shortness of breath; Leg cramps; Her legs wouldn't support her; A rash in the injection site that had spread to her upper arm; Arash in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness and aching on her leg), PAIN IN EXTREMITY (Aching on her leg), DYSPNOEA (Shortness of breath), MUSCLE SPASMS (Leg cramps) and LIMB DISCOMFORT (Her legs wouldn't support her) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.  Concomitant products included LISINOPRIL, OMEPRAZOLE, LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]), FENOFIBRATE, VITAMIN E [VITAMIN E NOS], PROBIOTICS NOS, ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VIT D3), ASCORBIC ACID (VIT C), CYANOCOBALAMIN (VIT B12) and CALCIUM for an unknown indication.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced MUSCULAR WEAKNESS (Weakness and aching on her leg), PAIN IN EXTREMITY (Aching on her leg), DYSPNOEA (Shortness of breath), MUSCLE SPASMS (Leg cramps), LIMB DISCOMFORT (Her legs wouldn't support her), RASH (A rash in the injection site that had spread to her upper arm) and VACCINATION SITE RASH (Arash in the injection site). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive the 2nd dose because of fear). At the time of the report, MUSCULAR WEAKNESS (Weakness and aching on her leg), PAIN IN EXTREMITY (Aching on her leg) and DYSPNOEA (Shortness of breath) had not resolved, MUSCLE SPASMS (Leg cramps), LIMB DISCOMFORT (Her legs wouldn't support her), RASH (A rash in the injection site that had spread to her upper arm) and VACCINATION SITE RASH (Arash in the injection site) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not receive the 2nd dose because of fear) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include calcium + bone strengthening and Others No treatment medications were reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Rash, Vaccination site rash
Clinical narrative: Did not receive the 2nd dose because of fear; Weakness and aching on her leg; Aching on her leg; Shortness of breath; Leg cramps; Her legs wouldn't support her; A rash in the injection site that had spread to her upper arm; Arash in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness and aching on her leg), PAIN IN EXTREMITY (Aching on her leg), DYSPNOEA (Shortness of breath), MUSCLE SPASMS (Leg cramps) and LIMB DISCOMFORT (Her legs wouldn't support her) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.  Concomitant products included LISINOPRIL, OMEPRAZOLE, LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]), FENOFIBRATE, VITAMIN E [VITAMIN E NOS], PROBIOTICS NOS, ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VIT D3), ASCORBIC ACID (VIT C), CYANOCOBALAMIN (VIT B12) and CALCIUM for an unknown indication.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced MUSCULAR WEAKNESS (Weakness and aching on her leg), PAIN IN EXTREMITY (Aching on her leg), DYSPNOEA (Shortness of breath), MUSCLE SPASMS (Leg cramps), LIMB DISCOMFORT (Her legs wouldn't support her), RASH (A rash in the injection site that had spread to her upper arm) and VACCINATION SITE RASH (Arash in the injection site). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive the 2nd dose because of fear). At the time of the report, MUSCULAR WEAKNESS (Weakness and aching on her leg), PAIN IN EXTREMITY (Aching on her leg) and DYSPNOEA (Shortness of breath) had not resolved, MUSCLE SPASMS (Leg cramps), LIMB DISCOMFORT (Her legs wouldn't support her), RASH (A rash in the injection site that had spread to her upper arm) and VACCINATION SITE RASH (Arash in the injection site) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not receive the 2nd dose because of fear) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include calcium + bone strengthening and Others No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Vaccination complication
Clinical narrative: The allergic reaction was even worse (after second dose); Reaction covered from her upper arm to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (The allergic reaction was even worse (after second dose)) and VACCINATION COMPLICATION (Reaction covered from her upper arm to her elbow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Malaria. Concurrent medical conditions included Fruit allergy (Mango, Chia, Antibiotics, and many others).   On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 26-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2021, the patient experienced CONDITION AGGRAVATED (The allergic reaction was even worse (after second dose)) and VACCINATION COMPLICATION (Reaction covered from her upper arm to her elbow). At the time of the report, CONDITION AGGRAVATED (The allergic reaction was even worse (after second dose)) and VACCINATION COMPLICATION (Reaction covered from her upper arm to her elbow) had resolved.            No concomitants are provided No treatments are provided   This case was linked to MOD-2021-213215 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not get 2nd Moderna dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Moderna dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Moderna dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Moderna dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.  No Treatment medications were reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Fatigue
Clinical narrative: Fatigue; gave three doses from one expired vial/ Vaccine given 1 day past expiration; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave three doses from one expired vial/ Vaccine given 1 day past expiration) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     Concurrent medical conditions included Systemic lupus erythematosus since 25-Aug-2019, Fibromyalgia since 30-Oct-2017 and GERD since 14-May-2019. Concomitant products included EPINEPHRINE (EPIPEN) for Allergic reaction, DIAZEPAM (VALIUM) and HYDROXYZINE EMBONATE (VISTARIL [HYDROXYZINE EMBONATE]) for Anxiety, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) and IBUPROFEN for Pain, CLOTRIMAZOLE (LOTRIMIN [CLOTRIMAZOLE]), CYPROHEPTADINE HYDROCHLORIDE (PERIACTIN), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), GABAPENTIN (NEURONTIN), LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL), MELOXICAM (MOBIC), MONTELUKAST SODIUM (SINGULAIR), RANITIDINE HYDROCHLORIDE (ZANTAC), ECONAZOLE NITRATE (SPECTAZOLE), NALOXONE, TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) and OMALIZUMAB (XOLAIR) for an unknown indication.    On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave three doses from one expired vial/ Vaccine given 1 day past expiration). On an unknown date, the patient experienced FATIGUE (Fatigue). On 26-Jul-2021, EXPIRED PRODUCT ADMINISTERED (gave three doses from one expired vial/ Vaccine given 1 day past expiration) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.  No temperature excursion of vial was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant follow-up received on 05-AUG-2021 and contains new information that are patient's height, weight, ethnicity, Medical History, and event, that is fatigue.
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jul-2021 and was forwarded to Moderna on 28-Jul-2021.    This spontaneous case was reported by a nurse and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Pustule, Rash
Clinical narrative: pustules all over; chest pain; rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PUSTULE (pustules all over), CHEST PAIN (chest pain) and RASH (rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PUSTULE (pustules all over), CHEST PAIN (chest pain) and RASH (rash). At the time of the report, PUSTULE (pustules all over), CHEST PAIN (chest pain) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown